ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1778

Physical Interactions Between Histidyl-tRNA Synthetase and Endogenous/Exogenous Alarmins Enhance Immunogenicity In a Model Of Antigen-Induced Myositis

Irina Fernandez1, Lisa Harlow2, William Ridgway3 and Dana P. Ascherman4, 1Rheumatology, University of Miami, Miami, FL, 2Rheumatology and Clinical Immunology, University of Miami Miller School of Medicine, Miami, FL, 3Immunology, Allergy and Rheumatology, University of Cincinnati, Cincinnati, OH, 4Medicine/Rheumatology, University of Miami Miller School of Medicine, Miami, FL

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: autoantigens, innate immunity, myositis and toll-like receptors

  • Tweet
  • Email
  • Print
Session Information

Title: Muscle Biology, Myositis and Myopathies I: Insights into Mechanisms of the Idiopathic Inflammatory Myopathies

Session Type: Abstract Submissions (ACR)

Objective:  To assess the biological interplay between histidyl-tRNA synthetase (HRS) and different endogenous/exogenous ligands capable of generating signals through MyD88-dependent receptor systems in idiopathic inflammatory myopathy.

Background/Purpose:  Recent immunohistochemical and array-based studies of human muscle tissue implicate Toll-like receptor (TLR)- and other MyD88-dependent signaling pathways in the pathogenesis of idiopathic inflammatory myopathy.  Our model of HRS-induced myositis replicates many of these observations, demonstrating that intramuscular immunization of mice with bacterially produced HRS fusion proteins preferentially triggers muscle inflammation (relative to other bacterially generated control proteins) via partially redundant MyD88-dependent signaling cascades.  However, the biophysical properties endowing HRS with this unique signaling capacity remain undefined.

Methods:   Binding interactions between eukaryotically expressed HRS and ligands of TLR2 (FSL-1), TLR4 (LPS), or RAGE (HMGB1) were assessed via standard solid phase ELISA following co-incubation of soluble HRS or TLR/RAGE ligands with defined concentrations of pre-bound substrate antigen.  As an alternative method for detection of HRS-TLR ligand complex formation, HRS and specified ligands were pre-incubated in solution for 2 hours prior to plating in BSA-blocked ELISA wells and subsequent probing with anti-HRS serum.  The ability of these complexes to signal via defined TLRs was assessed through stimulation of TLR-transfected HEK23 cells and measurement of resulting IL-8 production.

Results:  ELISA-based experiments demonstrated that both human and murine HRS expressed in a eukaryotic system bound HMGB1 in dose-dependent fashion.  Similarly, the TLR2 ligand FSL-1 formed complexes with baculovirus-expressed HRS that inhibited subsequent binding of HRS to BSA-blocked ELISA wells.  LPS also readily formed complexes with baculovirus-expressed HRS, as evidenced by diminished ELISA-based binding of these complexes relative to HRS alone.  Comparative ELISAs employing a biotinylated LPS/streptavidin-HRP probe system and various substrate antigens demonstrated that HRS bound LPS with 10-100 fold greater affinity/aviditiy than did ovalbumin or control autoantigens such as baculovirus-expressed Ro52.  Corresponding to these heightened interactions with the TLR ligands LPS and FSL-1, complexes of HRS-LPS and HRS-FSL-1 synergistically activated HEK293 cells transfected with TLR4 and TLR2, respectively—producing levels of IL-8 which significantly exceeded those induced by HRS or ligand alone.

Conclusion: HRS preferentially binds various ligands of innate immune receptors with high affinity, resulting in synergistic activation of TLR2- and TLR4-mediated signaling pathways that likely contribute to human idiopathic inflammatory myopathy as well as our model of HRS-induced myositis.  Of note, these findings support a more general paradigm in which autoantigens such as HRS bind endogenous/exogenous alarmins to activate innate immune signaling cascades that enhance immunogenicity and prime subsequent adaptive autoimmune responses.


Disclosure:

I. Fernandez,
None;

L. Harlow,
None;

W. Ridgway,
None;

D. P. Ascherman,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/physical-interactions-between-histidyl-trna-synthetase-and-endogenousexogenous-alarmins-enhance-immunogenicity-in-a-model-of-antigen-induced-myositis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology